NEO

NEO R&D Expense Growth

18.99%Fiscal year

Period ending:

NEO FY R&D Growth (YoY)%
NEO FY R&D Growth (YoY)370.48%-150.41%
2000-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

NEO r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 26 observations from Dec 31, 2000 to Dec 31, 2025.

Neogenomics Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
18.9929%
14.0979%
-9.9486%
38.6458%
165.8039%
-3.0399%
182.8057%
-17.4642%
-21.7896%
10.7432%
56.1175%
10.2049%
6.9706%
320.0737%
0%
0%
0%
0%
0%
0%
0%
0%
-100%
0%
0%
0%

Compare r&d expense growth

All NEO financial metrics · NEO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.